On September 8th, 2021— BASE10 Genetics, Inc., a technology company advancing precision medicine through disease management as a software, received approval by the Commonwealth of Kentucky to become a service provider in their K-12 School COVID-19 Testing Program.
Kentucky schools are experiencing an increase in the number of students and staff that are in quarantine or have tested positive for COVID-19, which has unfortunately led to one-fifth of the school districts temporarily closing for in-person learning. A comprehensive COVID-19 weekly testing program is an essential part in keeping outbreaks under control and providing a safe environment for in-person learning.
BASE10's Infection Control program offers COVID-19 testing, tracking, and reporting all under one Disease Management Platform. Since the start of the pandemic, BASE10 has been instrumental in partnering with organizations in long-term care to combat the COVID-19 pandemic through facilitating infection control practices, helping over 100 nursing homes across the country.
Rob Holton, Cofounder of BASE10 Genetics, Inc. said, “As a father of young twin daughters, I understand first-hand the importance and impact that the Delta variant is having on young children. Because of the significant success BASE10 has had protecting the most at-risk populations in many Kentucky long-term care facilities, we are truly honored to be part of the testing efforts in Kentucky school systems aimed at preventing the further spread of the disease.”
Kentucky’s K-12 School COVID-19 Testing Program is a voluntary program paid for by federal grant funding and offered by the Kentucky Department for Public Health (KDPH) in partnership with the Center for Disease Control (CDC) for Kentucky K-12 schools who wish to participate in school-based COVID-19 screening testing for teachers, staff, and students to assist schools in reopening safely for in-person instruction.
About BASE10 Genetics, Inc.
Located in Chicago, BASE10 is a healthcare software technology company whose platform creates turnkey disease management programs that can be deployed at scale for nursing home operators, pharmacies, payors, and self-funded employers.
Media inquiries: media@base10genetics.com
BASE10 Genetics, Inc. will not discriminate against anyone applying for or receiving assistance or services based on race, religion, color, national origin, sex, disability, age, political beliefs, or reprisal or retaliation for prior civil rights activity, or any other protected class identified in federal, state, or local laws.
